Human T-cell leukemia virus type 1: Transition from latent infection to pathogenic progression and implications for molecular therapy

Current Cancer Therapy Reviews

Volumn 2, Issue 2, 2006, Pages 101-113

  Tabakin Fix, Yulia ^a   Azran Shaish, Inbal ^a   Schavinsky Khrapunsky, Yana ^a   Chamias, Rachel ^c   Gohari, Lilach ^a   Huleihel, Mahmoud ^a   Li Weber, Min ^b   Aboud, Mordechai ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c NONE

Author keywords

Apoptosis; ATL; Genetic instability; HTLV 1; Tax; TSP HAM

Indexed keywords

TAX PROTEIN;

CARCINOGENICITY; DISEASE COURSE; DORMANCY; DRUG TARGETING; ENVIRONMENTAL FACTOR; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOTHERAPY; LATENT VIRUS INFECTION; LEUKEMOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; REVIEW; SPASTIC PARAPLEGIA; SPINAL CORD DISEASE; STRESS; T CELL LEUKEMIA; VIRUS ACTIVATION; VIRUS GENE; VIRUS INFECTION; VIRUS PATHOGENESIS;

EID: 33746114572     PISSN: 15733947     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339406776872843     Document Type: Review

References (156)

1. Albrecht B, Lairmore MD. Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis. Microbiol Mol Biol Rev 2002; 66: 396-406.
2. Kashanchi F, Brady JN. Transcriptional and post-transcriptional gene regulation of HTLV-1. Oncogene 2005; 24: 5938-51.
3. Felber BK, Paskalis H, Kleinman-Ewing C, Wong-Staal F, Pavlakis GN. The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats. Science 1985; 229: 675-9.
4. Younis I, Green PL. The human T-cell leukemia virus Rex protein. Front Biosci 2005; 10: 431-45.
5. Hidaka M, Inoue J, Yoshida M, Seiki M. Post-transcriptional regulator (rex) of HTLV-1 initiates expression of viral structural proteins but suppresses expression of regulatory proteins. EMBO J 1988; 7: 519-23.
6. Fan N, Gavalchin J, Paul B, Wells K, Lane MJ, Poiesz BJ. Infection of peripheral blood mononuclear cells and cell lines by cell-free human T-cell lymphoma/leukemia virus type-I. J Clin Microbiol 1992; 30: 905-10.
7. Igakura T, Stinchcombe JC, Goon PK, et al. Spread of HTLV-1 between lymphocytes by virus-induced polarization of the cytoskeleto. Science 2003; 299: 1713-6.
8. Bazarbachi A, Hermine O. Treatment of adult T-cell leukemia/lymphoma: current strategy and future prespective. Virus Res 2001; 78: 79-92.
9. Barmak K, Harhaj E, Grant C, Alefantis T, Wigdahl B. Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration. Virology 2003; 308: 1-12.
10. Yamada Y, Tomonaga M. The current status of therapy for adult T-cell leukaemia-lymphoma in Japan. Leuk, Lymphoma 2003; 44: 611-8.
11. Kannagi M, Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Masuda M. Adult T-cell leukemia: future prophylaxis and immunotherapy. Expert Rev Anticancer Ther 2004; 4: 369-76.
12. Matsumoto K, Shibata H, Fujisawa JI, et al. Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways. J Virol 1997; 71: 4445-51.
13. Ozden S, Coscoy L, Gonzalez-Dunia D. HTLV-I transgenic models: an overview. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13 (Suppl 1): S154-61.
14. waf1/Cip1/Sdi1 prevents apoptosis as well as stimulates growth in cells transformed or immortalized by human T-cell leukemia virus type 1-encoded Tax. J Virol 2003; 77: 7291-9.
15. Pise-Masison CA, Radonovich M, Mahieux R, et al. Transcription profile of cells infected with human T-cell leukemia virus type I compared with activated lymphocytes. Cancer Res 2002; 62: 3562-71.
16. Kwok RP, Laurance ME, Lundblad JR, et al. Control of cAMP-regulated enhancers by the viral trunsactivator Tax through CREB and the co-activator CBP. Nature 1996; 380: 642-6.
17. Franklin AA, Kubik MF, Uittenbogaard MN, et al. Transactivation by the human T-cell leukemia virus Tax protein is mediated through enhanced binding of activating transcription factor-2 (ATF-2) ATF-2 response and cAMP element-binding protein (CREB). J Biol Chem 1993; 268: 21225-31.
18. Suzuki T, Fujisawa J, Toita M, Yoshida M. The Trans-activator Tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-1. Proc Natl Acad Sci USA 1993; 90: 610-4.
19. Fujii M, Tsuchiya H, Chuhjo T, Minamino T, Miyamoto K, Seiki M. Serum response factor has functional roles both in indirect binding to the CArG box and in the transcriptional activation function of human T-cell leukemia virus type I Tax. J Virol 1994; 68: 7275-83.
20. Karin M, Lin A. NF-κB at the crossroads of life and death. Nat Immunol 2002; 3: 221-7.
21. Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-κB determines its association with CBP/p300 or HDAC-1. Mol Cell 2002; 9: 625-36.
22. Zhong H, Voll RE, Ghosh S. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell 1998; 1: 661-71.
23. Wang D, Westerheide SD, Hanson JL, Baldwin AS, Jr. Tumor necrosis factor-α-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II. J Biol Chem 2000; 275: 32592-7.
24. Madrid LV, Wang CY, Guttridge DC, Schottelius AJG, Baldwin ASJ, Mayo MW. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-κ B. Mol Cell Biol 2000; 20: 1626-38.
25. Duran A, Diaz-Meco MT, Moscat J. Essential role of RelA Ser311 phosphorylation by PKC-ζ in NF-κB transcriptional activation. EMBO J 2003; 22: 3910-8.
26. Harhaj EW, Harhaj NS. Mechanisms of persistent NF-κB activation by HTLV-I tax. IUBMB Life 2005; 57: 83-91.
27. Jeang KT. Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signalling through NF-κB. Cytokine Growth Factor Rev 2001; 12: 207-17.
28. Bex F, McDowall A, Burny A, Gaynor RB. The human T-cell leukemia virus type-I transactivator protein Tax colocalizes in unique structures with NF-κB proteins. J Virol 1997; 71: 3484-97.
29. Azran I, Jeang KT, Aboud M. High levels of cytoplasmic HTLV-1 Tax mutant proteins retain a Tax-NF-κB-CBP ternary complex in the cytoplasm. Oncogene 2005; 24: 4521-30.
30. Jaken S. Protein kinase C and tumor promoter. Curr Opin Cell Biol 1990; 2: 192-7.
31. Mellor H, Parker PJ. The extended protein kinase C superfamily. Biochem J 1998; 332: 281-92.
32. Nguyen-Ba G. Vasseur P. Epigenetic events during the process of cell transformation induced by carcinogens (review). Oncol Rep 1999; 6: 925-32.
33. Maruyama M, Shibuya H, Harada H, et al. Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1-encoded p40x and T3/Ti complex triggering. Cell 1987; 48: 343-50.
34. Tsukada J, Misago M, Serino Y, et al. Human T-cell leukemia virus type 1 Tax transactivates the promoter of human prointerleukin-1β gene through association with two trasncription factors, nuclear-interleukin-6 and Sp1. Blood 1997; 90: 3142-53.
35. Li-Weber M, Giaisi M, Chliclia K, Khazaie K, Krammer PH. Human T-cell leukemia virus type 1 Tax enhances IL-4 gene expression in T-cells. Europ J Immunol 2001; 31: 2623-32.
36. Li-Weber M, Giaisi M, Krammer PH. Roles of CCAAT/enhancer-binding protein in transcriptional regulation of the human IL-5 gene. Eur J Immunol 2001; 31: 3694-703.
37. Mori N, Shirakawa F, Abe M, et al. Human T-cell leukemia virus type I tax transactivates the interleukin-6 gene in human rheumatoid synovial cells. J Rheumatol 1995; 22: 2049-54.
38. Mori N, Shirakawa F, Abe M, et al. Human T-cell leukemia virus type I tax transactivates the interleukin-6 gene in human rheumatoid synovial cells. J Rheumatol 1995; 22: 2049-54.
39. Mori N, Mukaida N, Ballard DW, Matsushima K, Yamamoto N. Human T-cell leukemia virus type I Tax transactivates human interleukin 8 gene through acting concurrently on AP-1 and nuclear factor-kappaB-like sites. Cancer Res 1998; 58: 3993-4000.
40. Mori N, Gill PS, Mougdil T, Murakami S, Eto S, Prager D. Interleukin-10 gene expression in adult T-cell leukemia. Blood 1996; 88: 1035-45.
41. Azimi N, Brown K, Bamford RN, Tagaya Y, Siebenlist U, Waldmann TA. Human T cell lymphotropic virus type I Tax protein trans-activates interleukin 15 gene transcription through an NF-κB site. Proc Natl Acad Sci U S A 1998; 95: 2452-7.
42. Mariner JM, Lantz V, Waldmann TA, Azimi N. Human T-cell lymphotropic virus type I Tax activates IL-15Rα gene expression through an NF-κB site. J Immunol 2001; 166: 2602-9.
43. Himes SR, Coles LS, Katsikeros R, Lang RK, Shannon MF. HTLV-1 tax activation of the GM-CSF and G-CSF promoters requires the interaction of NF-κB with other transcription factor families. Oncogene 1993; 8: 3189-97.
44. Albrecht H, Shakhov AN, Jongeneel CV. Trans-activation of the tumor necrosis factor-α promoter by the human T-cell leukemia virus type I Tax1 protein. J Virol 1992; 66: 6191-3.
45. Santiago F, Clark E, Chong S, et al. Transcriptional up-regulation of the cyclin D2 gene and acquisition of new cyclin-dependent kinase partners in human T-cell leukemia virus type 1-infected cells. J Virol 1999; 73: 9917-27.
46. Neuveut C, Low KG, Maldarelli F, et al. Human T-cell leukemia virus type 1 Tax and cell cycle progression: role of cyclinD-cdk and p110Rb. Mol Cell Biol 1998; 18: 3620-32.
47. Neuveut C, Jeang KT. Cell cycle dysregulation by HTLV-I: role of the tax oncoprotein. Front Biosci 2002; 7: d157-63.
48. Wu K, Bottazzi ME, de la Fuente C, et al. Protein profile of Tax-associated complexes. J Biol Chem 2004; 279: 495-508.
49. Richardson JH, Edwards AJ, Cruickshank JK, Rudge P, Dalgleish AG. In vivo cellular tropism of human T-cell leukemia virus type 1] J Virol 1990; 64: 5682-7.
50. Pinsky BA, Biggins S. The spindle checkpoint: tension versus attachment. Trends Cell Biol 2005; 15: 486-93.
51. Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 2005; 5: 773-85.
52. Kasai T, Iwanaga Y, Iha H, Jeang KT. Prevalent loss of mitotic spindle checkpoint in adult T-cell leukemia confers resistance to microtubule inhibitors. J Biol Chem 2002; 277: 5187-93.
53. Marriott SJ, Lemoine FJ, Jeang KT. Damaged DNA and miscounted chromosomes: human T cell leukemia virus type I tax oncoprotein and genetic lesions in transformed cells. J Biomed Sci 2002; 9: 292-8.
54. Kamihira S, Atogami S, Sohda H, et al. DNA aneuploidy of adult T-cell leukemia cells. Leuk Res 1994; 18: 79-84.
55. Verschaeve L. Genetic effects of radiofrequency radiation (RFR). Toxicol Appl Pharmacol 2005; 207: 336-41.
56. Ramesh A, Walker SA, Hood DB, Guillen MD, Schneider K, Weyand EH. Bioavailability and risk assessment of orally ingested polycyclic aromatic hydrocarbons. Int J Toxicol 2004; 23: 301-33.
57. Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA. Environmental and chemical carcinogenesis. Semin Cancer Biol 2004; 14: 473-86.
58. Matsuda S, Nakao Y, Ohigashi H, Koshimizu K, Ito Y. Plant-derived diterpene esters enhance HTLV-I-induced colony formation of lymphocytes in co-culture. Int J Cancer 1986; 38: 859-65.
59. Van der Hoeven JC, Lagerwey WJ, Meeuwissen CA, Hauwert PC, Voragen AG, Koeman JX. Mutagens in food products of plant origin. Prog Clin Biol Res 1982; 109: 327-38.
60. Bernstein C, Bernstein H, Payne CM, Garewal H. DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: fail-safe protection against carcinogenesis. Mutat Res 2002; 511: 145-78.
61. Miyake H, Suzuki T, Hirai H, Yoshida M. Trans-activator Tax of human T-cell leukemia virus type 1 enhances mutation frequency of the cellular genome. Virology 1999; 253: 155-61.
62. Kao SY, Marriott SJ. Disruption of nucleotide excision repair by the human T-cell leukemia virus type 1 Tax protein. J Virol 1999; 73: 4299-304.
63. Lemoine FJ, Kao SY, Marriott SJ. Suppression of DNA repair by HTLV type 1 Tax correlates with Tax trans-activation of proliferating cell nuclear antigen gene expression. AIDS Res Hum Retroviruses 2000; 16: 1623-7.
64. Majone F, Jeang KT. Clastogenic effect of the human T-cell leukemia virus I tax oncoprotein correlates with unstabilized DNA breaks. J Biol Chem 2000; 275: 32906-10.
65. Philpott SM, Buehring GC. Defective DNA repair in cells with human T-cell leukemia/bovine leukemia viruses: role of tax gene. J Natl Cancer Inst 1999; 91: 933-42.
66. Jeang KT, Widen SG, Semmes OJT, Wilson SH. HTLV-I trans-activator protein, tax, is a trans-repressor of the human beta-polymerase gene. Science 1990; 247: 1082-4.
67. Jeang KT, Giam CZ, Majone F, Aboud M. Life, death and Tax: role of HTLV-I oncoprotein in genetic instability and cellular transformation. J Biol Chem 2004; 279: 31991-4.
68. Benhamou S, Sarasin A. Variability in nucleotide excision repair and cancer risk: a review. Mutat Res 2000; 462: 149-58.
69. Kawakami A, Nakashima T, Sakai H, et al. Inhibition of caspase cascade by HTLV-I Tax through inhibition of NF-κB nuclear translocation. Blood 1999; 94: 3847-54.
70. Brauweiler A, Garrus JE, Reed JC, Nyborg JK. Repression of Bax gene expression by the HTLV-I Tax protein: Implications for suppression of apoptosis in virally infected cells. Virology 1997; 231: 135-40.
71. Copeland KF, Haaksma AG, Goudsmit J, Krammer PH, Heeney JL. Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res Hum Retroviruses 1994; 10: 1259-68.
72. Torgeman A, Ben-Aroya Z, Grunspan A, et al. Activation of HTLV-I long terminal repeat by stress-inducing agents and protection of HTLV-I infected T-cells from apoptosis by the viral Tax protein. Exptl Cell Res 2001; 271: 169-79.
73. Mesnar JM, Devaux C. Multiple control levels of cell proliferation by human T-cell leukemia virus type 1 tax protein. Virology 1999; 257: 277-84.
74. Chen X, Zachar V, Zdravkovic M, Guo M, Ebbesen P, Liu X. Role of the Fas/ Fas ligand pathway in apoptotic cell death induced by the human T-cell lymphotropic virus type I Tax transactivator. J Gen Virol 1997; 78: 3277-85.
75. Kao SY, Leomine FJ, Marriott SJ. HTLV-I Tax protein sensitizes cells to apoptotic cell death induced by DNA damaging agents. Oncogene 2000; 19: 2240-8.
76. Kasai T, Jeang K. Two discrete events, human T-cell leukemia virus type I Tax oncoprotein expression and a separate stress stimulus, are required for induction of apoptosis in T-cells. Retrovirology 2004; 1: 7-18.
77. de la Fuente C, Wang L, Wang D, et al. Paradoxical effects of a stress signal on pro- and anti-apoptotic machinery in HTLV-1 Tax expressing cells. Mol Cell Biochem 2003; 245: 99-113.
78. Nilsson JA, Cleveland JL. Myc pathways provoking cell suicide and cancer. Oncogene 2003; 22: 9007-21.
79. Yoshida M, Osame M, Kawai H, et al. Increased replication of HTLV-I in HTLV-I-associated myelopathy. Ann Neurol 1989; 26: 331-5.
80. Fukushima N, Nishiura Y, Nakamura T, Yamada Y, Kohno S, Eguchi K. Involvement of p38 MAPK signaling pathway in IFN-γ and HTLV-I expression in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. J Neuroimmunol 2005; 159: 196-202.
81. Taylor GP, Hall SE, Navarrete S, et al. Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy. J Virol 1999; 73: 10289-95.
82. Yamano Y, Nagai M, Brennan M, et al. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8+ T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 2002; 99: 88-94.
83. Gessain A, Staal F, Gout O, Danniel MT, Flandrin G, deThe G, J.S P. T-cell lymphotropic virus type-I proviral load with polyclonal integration in peripheral blood mononuclear cells of French, West Indians, Guianese and African patients with tropical spastic paraparesis. Blood 1990; 75: 428-33.
84. Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol 1998; 4: 586-93.
85. Yao J, Wigdahl B. Human T-cell lymphotropic virus type I genomic expression and impact on intracellular signalling pathways during neurodegenerative disease and leukemia. Front Biosci 2000; 5: d138-68.
86. Lezin A, Olindo S, Oliere S, et al. Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: A new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis? J Infect Dis 2005; 191: 1830-4.
87. Cavrois M, Gessain A, Gout O, Wain-Hobson S, Wattel E. Common human T cell leukemia virus type 1 (HTLV-1) integration sites in cerebrospinal fluid and blood lymphocytes of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis indicate that HTLV-1 crosses the blood-brain barrier via clonal HTLV-1-infected cells. J Infect Dis 2000; 182: 1044-50.
88. Osame M, Matsumoto M, Usuku K, et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type-I and adult T-cell leukemia-like cells. Ann Neurol 1987; 21: 117-22.
89. Ceroni M, Piccardo P, Rogers-Johnson P, et al. Intrathecal synthesis of IgG antibodies to HTLV-I supports an etiological role for HTLV-I in tropical spastic paraparesis. Ann Neurol 1988; 23 suppl: 5188-91
90. Levin MC, Lee SM, Morcos Y, Brady J, Stuart J. Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry. J Infect Dis 2002; 186: 1514-7.
91. Kira J. The presence of HTLV-I proviral DNA in the central nervous system of patients with HTLV-I associated myelopathy/tropical spastic paraparesis. Neurology 1994; 44: 2295-9.
92. Lehky TJ, Fox CH, Koenig S, et al. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol 1995; 47: 176-5.
93. Mendez E, Kawanishi T, Clemens K, et al. Astrocyte-specific expression of human T-cell lymphotropic virus type 1 (HTLV-1) Tax: induction of tumor necrosis factor alpha and susceptibility to lysis by CD8+ HTLV-1-specific cytotoxic T cells. J Virol 1997; 71: 9143-9.
94. Lehky TJ, Cowan EP, Lampson LA, Jacobson S. Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells. J Virol 1994; 68: 1854-63.
95. Sawada M, Suzumura A, Yoshida M, Marunouchi T. T Human T-cell leukemia virus type-I trans activator induces class-I major histocompatibility complex antigen expression in glial cells. J Virol 1990; 64: 4002-6.
96. Hollsberg P. Mechanism of T-cell activation by human T-cell lymphotropic virus type I. Microbiol Mol Biol Rev 1999; 63: 308-33.
97. Itoyama Y, Kira J, Fujii N, Goto I, Yamamoto N. Increases in the helper inducer T-cells and activated T-cells in HTLV-I associated myelopathy. Ann Neurol 1989; 26: 257-63.
98. Tendler CL, Greenberg SJ, Blattner WA, et al. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc Natl Acad Sci U S A 1990; 87: 5218-22.
99. Marriott SJ, Trinh D, Brady JN. Activation of interleukin-2 receptor alpha expression by extracellular HTLV-I Tax1 protein: a potential role in HTLV-I pathogenesis. Oncogene 1992; 7: 1749-55.
100. Marriott SJ, Lindholm PF, Reid RL, Brady JN. Soluble HTLV-I Tax1 protein stimulates proliferation of human peripheral blood lymphocytes. New Biol 1991; 3: 678-86.
101. Moritoyo T, Izumo S, Moritoyo H, et al. Detection of human T-lymphotropic virus type I p40tax protein in cerebrospinal fluid cells from patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Neuroimmunol 1999; 5: 241-8.
102. Jacobson S, D.E M, Robinson S, Voskuhl R, Martin R, Brewah AJ, Koenig S. Demonstration of HTLV-I specific cytotoxic T-lymphocytes in the cerebrospinal fluid of patients with HTLV-I associated neurological disease. Ann Neurol 1992; 32: 651-7.
103. Kubota R, Nagai M, Kawanishi T, Osame M, Jacobson S. Increased HTLV-I Tax-specific CD8+ cells in HTLV type I-associated myelopathy/tropical spastic paraparesis: Correlation with HTLV type I proviral load. AIDS Res Hum Retroviruses 2000; 16: 1705-9.
104. Makino M, Shimokubo S, Wakamatsu SI, Izumo S, Baba M. The role of human T-lymphotropic virus type 1 (HTLV-1)-infected dendritic cells in the development of HTLV-1-associated myelopathy/tropical spastic paraparesis. J Virol 1999; 73: 4575-81.
105. Umehara F, Nakamura A, Izumo S, et al. Apoptosis of T-lymphocytes in the spinal cord lesion in HTLV-I associated myelopathy: A possible mechanism to control viral infection in the central nervous system. J Neropathol Exptl Neurol 1994; 53: 617-24.
106. Tsukamoto T, Iwasaki Y, Osame M, Usuku K, Igata A. Myelinotoxic CSF from patients with HTLV-I associated myelopathy (HAM). Adv Neurol Sci 1987; 31: 759-65.
107. Hara H. Autoimmune mechanism in HAM/TSP. Nippon Rinsh 1994; 52: 2919-25.
108. Hollsberg P. Pathogenesis of chronic progressive myelopathy associated with human T-cell lymphotropic virus type I. Acta Neurol Scand Suppl 1997; 169: 86-93.
109. Hinuma S, Sugamura K, Tsukamoto K, Hinuma Y. Constitutive production of phagocytosis inducing factor(s) in a monocyte/macrophage lineage cell line (THP-1) by retrovirus transformed human T-cell lines. Microbiol Immunol 1984; 28: 935-47.
110. Abe M, Umehara F, Kubota R, Moritoyo T, Izumo S, Osame M. Activation of macrophages/microglia with the calcium-binding proteins MRP14 and MRP8 is related to the lesional activities in the spinal cord of HTLV-I associated myelopathy. J Neurol 1999; 246: 358-64.
111. Romero IA, Prevost MC, Perret E, et al. Interactions between brain endothelial cells and human T-cell leukemia virus type 1-infected lymphocytes: Mechanisms of viral entry into the central nervous system. J Virol 2000; 74: 6021-30.
112. Becher B, Prat A, Antel JP. Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia 2000; 29: 293-304.
113. Janzer RC. The blood-brain barrier: cellular basis. J Inherit Metab Dis 1993; 16: 639-47.
114. Mor-Vaknin N, Turgeman H, Torgeman A, Wolfson M, Huleihel M, Aboud M. Rapid syncytia formation between human T-cell leukemia virus type-I (HTLV-I)-infected T-cells and humanan nervous system cells: A possible implication for tropical/spastic paraparesis/HTLV-Iassociated myelopathy. Cell Biol Int 1998; 22: 95-103.
115. Szymocha R, Brisson C, Bernard A, Akaoka H, Belin MF, Giraudon P. Long-term effects of HTLV-1 on brain astrocytes: sustained expression of Tax-1 associated with synthesis of inflammatory mediators. J Neurovirol 2000; 6: 350-7.
116. Giraudon P, Szymocha R, Burat S, et al. T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinase and their endogenous inhibitor, TIMPs, in human astrocytes: relevance to HTLV-I induced neurological disease. J Immunol 2000; 164: 2718-27.
117. Mori N, Ueda A, Ikeda S, et al. Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-κB sites. Cancer Res 2000; 60: 4939-45.
118. Joseph J, Lublin FD, Knobler RL. Modulation of T cell-endothelial adhesion by astrocyte conditioned medium. Glia 1997; 21: 408-12.
119. Weiss JM, Downie SA, Lyman WD, Berman JW. Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of human blood-brain barrier. J Immunol 1998; 161: 6896-903.
120. Kinoshita T, Shimoyama M, Tobinai K, et al. Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc Natl Acad Sci U S A 1989; 86: 5620-4.
121. Tochikura T, Iwahashi M, Matsumoto T, Koyanagi Y, Hinuma Y, Yamamoto N. Effect of human serum anti-HTLV antibodies on viral antigen induction in vitro cultured peripheral lymphocytes from adult T-cell leukemia patients and healthy virus carriers. Int J Cancer 1985; 36: 1-7.
122. Hanon E, Hall S, Taylor GP, et al, Bangham CRM. Abundant Tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 2000; 95: 1386-92.
123. Etoh K, Tamiya S, Yamaguchi K, et al. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. Cancer Res 1997; 57: 4862-7.
124. Bangham CRM. The immune control and cell-to-cell spread of human T-lymphotropic virus type 1. J Gen Virol 2003; 84: 3177-89.
125. Revazova T, Dombrovsky A, Lochelt M, Flugel RM, Aboud M. Tax-independent stimulation of human T-cell leukemia virus type-I expression and differential effects on its infectivity by subtoxic and toxic doses of 3-methylcholantherene. Cell Mol Biol Res 1995; 41: 377-85.
126. Mor-Vaknin N, Torgeman A, Galron D, Lochelt M, Flugel RM, Aboud M. The long terminal repeats of human immunodeficiency virus type-1 and human T-cell leukemia virus type-I are activated by 12-O-tetradecanoylphorbol-13-acetate through different pathways. Virology 1997; 232: 337-44.
127. Torgeman A, Mor-Vaknin N, Zelin E, et al. Sp1-p53 heterocomplex mediates activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate that is antagonized by protein kinase C. Virology 2001; 281: 10-20.
128. Baier-Bitterlich G, Baier G, Fuchs D, et al. Role of 7,8-dihydroneopterin in T-cell apoptosis and HTLV-I transcription in vitro. Oncogene 1996; 13: 2281-5.
129. Arima N, Arimura K, Tokito Y, et al. HTLV-1 Tax protein inhibits apoptosis but not G1 arrest by pyrrolidinedithiocarbamate, an antioxidant, in adult T-cell leukemia cells. Exptl Hematol 2004; 32: 195-201.
130. Torgeman A, Mor-Vaknin N, Aboud M. Sp1 is involved in protein kinase C independent activation of HTLV-I long terminal repeat by 12-O-tetradecanoylphorbol-13-acetate. Virology 1999; 254: 279-87.
131. (WAF-1) expression by 12-O-tetradecanoyl-13-phorbol acetate in human T-cells. Oncogene 2003; 22: 3515-24.
132. WAF-1 promoter in human T-cells through its second upstream Sp1 site. Biochem Biophys Res Commun 2003; 304: 696-700.
133. Gorospe M, Wang X, Hokbrook NJ. Functional role of p21 during the cellular response to stress. Gene Expr 1999; 7: 377-85.
134. Gervais JLM, Seth P, Zhang H. Cleavage of CDK inhibitor p21(Cip1/waf1) by caspase is an early event during DNA damage-induced apoptosis. J Biol Chem 1988; 273: 19207-12.
135. Takeda S, Maeda M, Morikawa S, et al. Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer 2004; 109: 559-67.
136. Yamada Y, Kamihira S. Inactivation of tumor suppressor genes and the progression of adult T-cell leukemia-lymphoma. Leuk Lymphoma 2005; 46: 1553-9.
137. Tamiya S, Etoh K, Suzushima H, Takatsuki K, Matsuoka M. Mutation of CD95 (Fas/Apo-1) gene in adult T-cell leukemia cells. Blood 1998; 91: 3935-42.
138. Yasunaga J, Taniguchi Y, Nosaka K, et al. Identification of aberrantly methylated genes in association with adult T-cell leukemia. Cancer Res 2004; 64: 6002-9.
139. Kamihira S, Yamada Y, Hirakata Y, et al. Aberrant expression of caspase cascade regulatory genes in adult T-cell leukaemia: survivin is an important determinant for prognosis. Br J Haematol 2001; 114: 63-9.
140. Mori N, Yamada Y, Hata T, et al. Expression of survivin in HTLV-I-infected T-cell lines and primary ATL cells. Biochem Biophys Res Commun 2001; 282: 1110-3.
141. Sugahara K, Uemura A, Harasawa H, et al. Clinical relevance of survivin as a biomarker in neoplasms, especially in adult T-cell leukemias and acute leukemias. Int J Hematol 2004; 80: 52-8.
142. Yamada Y, Hatta Y, Murata K, et al. Deletion of p15 and/or p16 genes as a poor-prognosis factor in adult T-cell leukemia. J Clin Oncol 1997; 15: 1778-85.
143. Fujiwara H, Arima N, Hashimoto-Tamaoki T, et al. Alteration of p16 (CDKN2) gene is associated with interleukin-2-induced tumor cell growth in adult T-cell leukemia. Exp Hematol 1999; 27: 1004-9.
144. Hatta Y, Spirin K, Tasaka T, et al. Analysis of p18INK4C in adult T-cell leukaemia and non-Hodgkin's lymphoma. Br J Haematol 1997; 93: 665-7.
145. KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/ lymphoma. Blood 1995; 86: 1924-30.
146. Higuchi M, Matsuda T, Mori N, et al. Elevated expression of CD30 in adult T-cell leukemia cell lines: possible role in constitutive NF-kappaB activation. Retrovirology 2005; 2: 29-40.
147. Matsuoka M. Human T-cell leukemia virus type I (HTLV-I) infection and the onset of adult T-cell leukemia (ATL). Retrovirology 2005; 2: 27.
148. Jeffery KJ, Usuku K, Hall SE, et al. HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc Natl Acad Sci USA 1999; 70: 3848-53.
149. Sabouri AH, Saito M, Usuku K, et al. Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals. J Gen Virol 2005; 86: 773-81.
150. Kodama D, Saito M, Matsumoto W, et al. Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP). J Neuroimmunol 2004; 156: 188-94.
151. Brady J, Jeang KT, Duvall J, Khoury G. Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat. J Virol 1987; 61: 2175-81.
152. Bex F, Yin MJ, Burny A, Gaynor RB. Differential transcriptional activation by human T-cell leukemia virus type 1 Tax mutants is mediated by distinct interactions with CREB binding protein and p300. Mol Cell Biol 1998; 18: 2392-405.
153. Jin DY, Giordano V, Kibler KV, Nakano H, Jeang KT. Role of adapter function in oncoprotein-mediated activation of NF-κB. Human T-cell leukemia virus type I Tax interacts directly with IκB. J Biol Chem 1999; 274: 17402-5.
154. Harhaj EW, Sun SC. IKKγ serves as a docking subunit of the IκB kinases (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J Biol Chem 1999; 274: 22911-4.
155. Harai H, Suzuki T, Fujisawa J, Inoue J, Yoshida M. Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor κB and induces nuclear translocation of transcription factor NF-κB proteins for transcriptional activation. Proc Natl Acad Sci U S A 1994; 91: 3584-8.
156. Li XH, Gaynor RB. Mechanisms of NF-κB activation by the HTLV type 1 Tax protein. AIDS Res Human Retroviruses 2000; 16: 1583-90.